(Q44454415)

3 December 2017

title

Recurrence of cryptococcal meningitis in HIV-infected patients following immune reconstitution (English)

1 reference

3 December 2017

1 reference

cryptococcal meningitis

1 reference

4

1 reference

3 December 2017

J Seddon

1

1 reference

3 December 2017

N Mangeya

series ordinal

2

1 reference

3 December 2017

R F Miller

series ordinal

3

1 reference

3 December 2017

R A Ferrand

series ordinal

5

1 reference

3 December 2017

publication date

1 April 2009

1 reference

International Journal of STD & AIDS

3 December 2017

published in

1 reference

3 December 2017

volume

20

1 reference

3 December 2017

issue

4

1 reference

3 December 2017

page(s)

274-275

1 reference

Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008312

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008312

Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008312

Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008312

Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008312

Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008312

Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008312

Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008312

Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008312

Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008312

Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008312

Relapsing meningitis caused by persistent cryptococcal antigens and immune reconstitution after the initiation of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008312

Fungal Burden, Early Fungicidal Activity, and Outcome in Cryptococcal Meningitis in Antiretroviral-Naive or Antiretroviral-Experienced Patients Treated with Amphotericin B or Fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008312

21 January 2018

Identifiers

DOI

10.1258/IJSA.2008.008312

1 reference

3 December 2017

1 reference